Protagonist Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	209.18	434.43	60	26.58	27.36	28.63	Upgrade
Revenue Growth (YoY)	-34.45%	624.05%	125.72%	-2.84%	-4.44%	12293.07%	Upgrade
Gross Profit	209.18	434.43	60	26.58	27.36	28.63	Upgrade
Selling, General & Admin	41.4	43.46	33.49	31.74	27.2	18.64	Upgrade
Research & Development	143.8	138.13	120.16	126.22	126.01	74.51	Upgrade
Operating Expenses	185.2	181.59	153.65	157.95	153.2	93.14	Upgrade
Operating Income	23.98	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
Interest Expense	-	-	-	-	-	-0.6	Upgrade
Interest & Investment Income	29.51	26.32	14.9	4.06	0.44	0.9	Upgrade
Currency Exchange Gain (Loss)	0.29	0.25	-0.2	-0.08	-0.15	-0.05	Upgrade
EBT Excluding Unusual Items	53.78	279.41	-78.96	-127.39	-125.55	-64.26	Upgrade
Other Unusual Items	-	-	-	-	-	-0.59	Upgrade
Pretax Income	53.78	279.41	-78.96	-127.39	-125.55	-64.85	Upgrade
Income Tax Expense	1.74	4.22	-	-	-	1.31	Upgrade
Net Income	52.04	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Net Income to Common	52.04	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Shares Outstanding (Basic)	63	62	57	49	46	34	Upgrade
Shares Outstanding (Diluted)	65	65	57	49	46	34	Upgrade
Shares Change (YoY)	4.64%	14.65%	15.74%	5.87%	34.67%	32.84%	Upgrade
EPS (Basic)	0.83	4.47	-1.39	-2.60	-2.71	-1.92	Upgrade
EPS (Diluted)	0.80	4.23	-1.39	-2.60	-2.71	-1.92	Upgrade
Free Cash Flow	37.1	182.8	-70.85	-108.93	-108.97	-72.96	Upgrade
Free Cash Flow Per Share	0.57	2.81	-1.25	-2.22	-2.35	-2.12	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	11.46%	58.20%	-156.09%	-494.24%	-460.01%	-225.36%	Upgrade
Profit Margin	24.88%	63.34%	-131.59%	-479.26%	-458.94%	-231.07%	Upgrade
Free Cash Flow Margin	17.73%	42.08%	-118.08%	-409.81%	-398.31%	-254.84%	Upgrade
EBITDA	24.87	253.67	-92.68	-130.34	-125.03	-63.57	Upgrade
EBITDA Margin	11.89%	58.39%	-154.46%	-	-	-222.05%	Upgrade
D&A For EBITDA	0.89	0.83	0.98	1.03	0.81	0.95	Upgrade
EBIT	23.98	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
EBIT Margin	11.46%	58.20%	-156.09%	-	-	-225.36%	Upgrade
Effective Tax Rate	3.24%	1.51%	-	-	-	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q